W John Smither
Affiliations
- at Newamsterdam Pharma Co N.v. (NAMS), 2025-01-08
- at Genelux Corp (GNLX), 2024-12-31
- Chief Financial Officer at Arcutis Biotherapeutics Inc. (ARQT), 2024-02-15
- Director at Applied Molecular Transport Inc. (AMTI), 2023-12-28
- Director at Effector Therapeutics Inc. (EFTR), 2023-06-23
- Director at Principia Biopharma Inc. (PRNB), 2019-02-21
- Chief Financial Officer at Sienna Biopharmaceuticals Inc. (SNNA), 2019-01-03
- Director at Achaogen Inc (AKAO), 2018-06-07
- Chief Financial Officer at Kythera Biopharmaceuticals Inc (KYTH), 2015-10-02
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| GNLX | $0.00 | 6,250 | $0.00 | 13,170 | 2024-05-29 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| GNLX | $20.78 | 900 | $18,702.00 | 6,920 | 2023-09-13 | Filing |
| ARQT | $32.90 | 1,250 | $41,125.00 | 86,715 | 2021-03-10 | Filing |
| ARQT | $32.90 | 500 | $16,450.00 | 46,321 | 2021-03-10 | Filing |
| ARQT | $34.20 | 773 | $26,439.69 | 24,425 | 2021-03-01 | Filing |
| ARQT | $35.64 | 2,000 | $71,280.00 | 87,965 | 2021-02-10 | Filing |